Results 21 to 30 of about 58,279 (299)

A BAF’ling Approach to Curing HIV [PDF]

open access: yesCell Chemical Biology, 2018
Latency is the primary barrier to the development of a long-sought cure for HIV-1. In this issue of Cell Chemical Biology, Marian et al., (2018) describe the development of novel compounds targeting the BAF chromatin remodeling complex to reverse HIV latency, with the potential to provide a functional cure.
Tomar, Sakshi   +2 more
openaire   +4 more sources

Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes [PDF]

open access: yes, 2012
BACKGROUND: In Switzerland and other developed countries, the number of tuberculosis (TB) cases has been decreasing for decades, but HIV-infected patients and migrants remain risk groups.
Thomas Bodmer   +63 more
core   +1 more source

International AIDS Society global scientific strategy: towards an HIV cure 2016 [PDF]

open access: yes, 2016
Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a global population of more than 35 million people living with HIV, there is intense interest in developing a cure for HIV infection.
Chen, Z   +1 more
core   +1 more source

Modelling tuberculosis in areas of high HIV prevalence [PDF]

open access: yes, 2006
We describe a discrete event simulation model of tuberculosis (TB) and HIV disease, parameterized to describe the dual epidemics in Harare, Zimbabwe. TB and HIV are the leading causes of death from infectious disease among adults worldwide and the number
Hughe, Georgina R.   +5 more
core   +1 more source

Barriers to a cure for HIV in women [PDF]

open access: yesJournal of the International AIDS Society, 2016
IntroductionDistinct biological factors exist that affect the natural history of HIV and the host immune response between women and men. These differences must be addressed to permit the optimal design of effective HIV eradication strategies for much of the HIV‐positive population.Methods and resultsHere, we review the literature on sex‐based ...
Gianella, Sara   +3 more
openaire   +7 more sources

Religion and HIV in Tanzania: Influence of Religious Beliefs on HIV stigma, Disclosure, and Treatment Attitudes. [PDF]

open access: yes, 2009
Religion shapes everyday beliefs and activities, but few studies have examined its associations with attitudes about HIV. This exploratory study in Tanzania probed associations between religious beliefs and HIV stigma, disclosure, and attitudes toward ...
Yvonne Yamanaka   +11 more
core   +1 more source

HIV and tuberculosis in Ho Chi Minh City, Vietnam, 1997-2002. [PDF]

open access: yes, 2007
In Ho Chi Minh City, Vietnam, reporting rates for tuberculosis (TB) are rising in an emerging HIV epidemic. To describe the HIV epidemic among TB patients and quantify its impact on rates of reported TB, we performed a repeated cross-sectional survey ...
Borgdorff, Martien W   +14 more
core   +1 more source

Prospective interruption of therapy towards a cure for HIV (PITCH): experiences of patients on treatment interruption (TI) [PDF]

open access: yes, 2020
Background: Increasingly cure trials require a treatment interruption (TI) in order to evaluate whether an intervention has worked. In order to ensure that future TI trials are designed sensitively with participants at the heart of the process, we ...
Fox, J   +8 more
core   +1 more source

Novel therapies/hopes for HIV cure in perinatally acquired HIV-positive adolescents. [PDF]

open access: yes, 2018
PURPOSE OF REVIEW: Successful roll-out of paediatric antiretroviral therapy (ART) has led to a significant increase in survival of adolescents and young people growing up with HIV.
Thomas Joshua Pasvol   +8 more
core   +2 more sources

Understanding HIV Latency: The Road to an HIV Cure [PDF]

open access: yesAnnual Review of Medicine, 2015
Treatment with antiretroviral therapy dramatically increases the survival of HIV-infected individuals. However, treatment has to be continued for life because it does not lead to the full eradication of infection. HIV persists in resting CD4+ T cells, and possibly other cell types, and can reemerge from these cells when therapy is interrupted.
Matthew S, Dahabieh   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy